Research Topics
Species | N Avrion MitchisonSummaryAffiliation: University College London Country: UK Publications
| Collaborators |
Detail Information
Publications
Patterned variation in murine MHC promotersN Avrion Mitchison
Department of Immunology, Windeyer Institute of Medical Science, 46 Cleveland Street, London W1T 4JF, United Kingdom
Proc Natl Acad Sci U S A 99:10561-6. 2002..The dimorphic allelic lineages are in marginally detectable linkage disequilibrium with the exon 2 sequences, particularly in H2Aa, thus lending further support to the coevolution hypothesis...
Human congenital diseases with mixed modes of inheritance have a shortage of recessive disease. A demographic scenario?N Avrion Mitchison
Institute of Ophthalmology, University College London, London EC1V 9EL, UK
Ann Hum Genet 75:688-93. 2011..The deficit fits well with the standard model of demographic change since the neolithic era, and may also reflect natural selection acting on heterozygotes...
From ENU mutagenesis to population geneticsN Avrion Mitchison
Institute of Ophthalmology, University College London, London, UK
Mamm Genome 19:221-5. 2008
A survey of H2 gene sequences, including new wild-derived genesN A Mitchison
Department of Immunology and Molecular Pathology, University College London, Windeyer Building, 46 Cleveland Street, London W1T 4JF, UK
Int J Immunogenet 34:3-12. 2007..The H2Eb(p) alleles form a distinct group, associated with their lack of the recombination hot spot located between exon 2 and exon 3. The collection is expected to prove useful in guiding functional and evolutionary studies...
Fundamental immunology and what it can teach us about HIV vaccine developmentN Avrion Mitchison
Department of Immunology, Windeyer Institute of Medical Science, London, UK
Curr Drug Targets Infect Disord 5:87-93. 2005..Finally we urge that vaccine trials should include storage of individual DNA samples, in order to gain better understanding of the genetic parameters of vaccine efficacy...
Does the polymorphism of MHC class II promoters matter?N A Mitchison
Department of Immunology, Windeyer Institute of Medical Science, 46 Cleveland Street, London W1T 4JF, UK
Cell Immunol 233:162-5. 2005....
Conditional haploinsufficiency of NCF1 (encoding p47(phox)), a signaling gene with a heterozygous phenotype potentially subject to natural selectionN A Mitchison
Department of Immunology and Molecular Pathology, Windeyer Institute of Medical Sciences, University College London, 46 Cleveland Street, London W1T 4JF, UK
Immunol Lett 97:63-7. 2005..In view of recent re-evaluation of the role of the respiratory burst these findings are compatible with the view that haploinsufficiency occurs particularly among rate-limiting genes that operate in regulatory/signaling pathways...
T-cell-B-cell cooperationN A Mitchison
Department of Immunology, Windeyer Institute of Medical Science, 46 Cleveland Street, London W1T 4JF, UK
Nat Rev Immunol 4:308-12. 2004
Self/nonself discrimination among immunoregulatory (CD4) T cellsN A Mitchison
Department of Immunology, Windeyer Institute of Medical Sciences, 46 Cleveland Street, London, W1P 6DB
Semin Immunol 12:179-83; discussion 257-344. 2000..Activation induced cell death, containment, anergy and deviation constitute subsidiary mechanisms, and sequestration/neglect is important in limiting the scope of deletion...
Polymorphism in regulatory gene sequencesN A Mitchison
Department of Immunology, Windeyer Institute of Medical Science, University College London Medical School, Cleveland Street, London W1P 6DB, UK
Genome Biol 2:COMMENT2001. 2001....
Natural variation in immune responsiveness, with special reference to immunodeficiency and promoter polymorphism in class II MHC genesN A Mitchison
Department of Immunology, University College London Medical School, UK
Hum Immunol 61:177-81. 2000..MHC class II gene promoters differ in their capacity to favor Th1 (or reciprocally Th2) responses, thus suggesting that promoter polymorphism is sustained by the greater flexibility in response that this confers on heterozygotes...
Aqueous humor alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejectionT H Flynn
Department of Ocular Immunology, UCL Institute of Ophthalmology, London, UK
Am J Transplant 8:1537-43. 2008..Aqueous humor samples offer a unique opportunity to analyze components of the allogeneic response in direct contact with donor tissue but without artifacts inherent in examination of tissue...
The immunological synapseR J Creusot
Windeyer Institute of Medical Science, University College London, 46 Cleveland Street, W1T 4JF, UK
Mol Immunol 38:997-1002. 2002..In exploring this form of control we are learning something of general importance about cis-regulation...
Testing the theory of immune selection in cancers that break the rules of transplantationAriberto Fassati
MRC Centre for Medical Molecular Virology, University College London, UK
Cancer Immunol Immunother 59:643-51. 2010..Here, we (a) survey old and new transplantation experiments that test the possibility of selection and (b) survey how transmissible tumours of dogs and Tasmanian devils provide naturally evolved tests of immune surveillance...
Epistasis: the key to understanding immunological disease?N Avrion Mitchison
Department of Genetics, UCL Institute of Ophthalmology, London, UK
Eur J Immunol 41:2152-4. 2011..A study in this issue of the European Journal of Immunology uses in-depth analysis of genome-wide mapping by polymorphic microsatellite markers to shed light on the genomic control of autoimmunity and self-tolerance...
Variable response to a candidate cancer vaccine antigen: MHC control of the antibody response in the rat to avian erythroblastosis virus (AEV)-encoded epithelial growth factor receptor but not AEV-encoded thyroid hormones receptorN Nardi
Imperial Cancer Research Fund Tumor Immunology Unit, University College London, United Kingdom
Mol Med 1:563-7. 1995....
The role of HLA promoters in autoimmunityBrigitte Müller-Hilke
Institute of Immunology, Medical Faculty, Schillingallee 70, 18055 Rostock, Germany
Curr Pharm Des 12:3743-52. 2006..We here summarise our knowledge of HLA promoter polymorphisms and how these translate into differential expression, T cell polarisation and inflammation. We discuss current strategies for pharmaceutical intervention in HLA expression...
